Moderna (MRNA) Q4 2022 Earning Report Analysis
- Quarterly revenue: $5.08 billion, a 6% decrease from Q3 2022;- Quarterly earnings: $3.61 per share, a 35% decrease from Q3 2022;- Lowered 2023 revenue guidance for Covid vaccine sales…
- Quarterly revenue: $5.08 billion, a 6% decrease from Q3 2022;- Quarterly earnings: $3.61 per share, a 35% decrease from Q3 2022;- Lowered 2023 revenue guidance for Covid vaccine sales…
- Quarterly revenue: $222.6 billion RMB, up 7.4% quarter over quarter;- Quarterly earnings: $1.82 per share, up 21.3% quarter over quarter;- Product focused on new initiatives such as cloud computing,…
- The company reported a quarterly revenue of $451 million, which was a 43% increase year-over-year.- The company reported a net loss of $144.7 million for Q3 2022, compared to…